Financial

Codman Neuro Announces Acquisition Of Neuravi Limited To Accelerate Innovation In Acute Ischemic Stroke Therapy

NEWS PROVIDED BY Codman Neuro | 10 Apr, 2017, 07:00 ET IRVINE, Calif., April 10, 2017 /PRNewswire/ — Codman Neuro today announced the acquisition of Neuravi Limited, a privately held Irish company dedicated to advancing neurovascular therapies and improving clinical outcomes for acute ischemic stroke patients. This acquisition, and the recent […]

SoCal’s Endologix Gets $170 Million Injection to Advance Aortic Disorder Treatment

Endologix Enters into $170 Million Credit Facility with Deerfield Management IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it has entered into an agreement with Deerfield Management (“Deerfield”), a leading healthcare investment organization, to provide Endologix with up to $170 […]

Utah’s Merit Medical (MMSI) Prices $136.5 Million Offering

Merit Medical Announces Closing of Public Offering of Common Stock SOUTH JORDAN, Utah, March 29, 2017 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI) (“Merit”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy, today announced that […]

Boston Scientific agrees to acquire Symetis

MARLBOROUGH, Mass., March 30, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices, for $435 million in up-front cash. The Symetis portfolio includes the ACURATE TA™ and ACURATE neo/TF valve* […]

Arrhythmia Research Technology, Inc. Reports 2016 Fourth Quarter and Year End Results

FITCHBURG, Mass., March 22, 2017 (GLOBE NEWSWIRE) — Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the “Company”), through its wholly-owned subsidiary, Micron Products, Inc., a diversified contract manufacturing organization that produces highly-engineered, innovative medical device components requiring precision machining and injection molding, announced results for its fourth quarter and year ended […]

Bay Area’s Cardiva Med Banks $30 Million

Cardiva Medical Raises $30 Million – >Financing to Fuel Commercial Growth of VASCADE Vascular Closure System and Development of Next Generation Products for Vascular Closure SANTA CLARA, Calif., March 14, 2017 /PRNewswire/ — Cardiva Medical, an innovator in the field of vascular closure, today announced that the company has completed […]